Table of Contents
Washington University Experience | MYELIN (NON-IMMUNE MEDIATED) | Retinal Vasculopathy with Cerebral Leukoencephalopathy (RVCL, TREX1 Mutation) | 15H2 CRV (Case 15) A3 Ki67 20X 1
There is a significant amount of staining for the proliferative marker Ki67 but it mostly involves proliferated vasculature with some inflammatory cell labeling (Ki67 IHC)
